img

Global Insulin API Sales Market Report 2024


Published on: 2024-01-04 | No of Pages : 144 | Industry : Pharma & Healthcare

Publisher : q | Format : PDF

Global Insulin API Sales Market Report 2024

The global Insulin API market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Insulin API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Regular Human Insulin
Insulin Analogue


Segment by Application


Fast-Acting
Premix
Long-Acting

The Insulin API market is analysed and market size information is provided by regions (countries).

Segment by Application

, the Insulin API market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.




By Company


Novo Nordisk
Sanofi-Aventis
Eli Lilly
Tonghua Dongbao
Ganlee
United Laboratory
Biocon
Amphastar
Wockhardt
Julphar Diabetes
Torrent Pharma

Table of Content

1 Insulin API Market Overview
1.1 Insulin API Product Scope
1.2 Insulin API Segment by Type
1.2.1 Global Insulin API Sales by Type (2016 & 2021 & 2027)
1.2.2 Regular Human Insulin
1.2.3 Insulin Analogue
1.3 Insulin API Segment by Application
1.3.1 Global Insulin API Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Fast-Acting
1.3.3 Premix
1.3.4 Long-Acting
1.4 Insulin API Market Estimates and Forecasts (2016-2027)
1.4.1 Global Insulin API Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Insulin API Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Insulin API Price Trends (2016-2027)

2 Insulin API Estimates and Forecasts by Region
2.1 Global Insulin API Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Insulin API Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Insulin API Sales Market Share by Region (2016-2021)
2.2.2 Global Insulin API Revenue Market Share by Region (2016-2021)
2.3 Global Insulin API Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Insulin API Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Insulin API Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Insulin API Estimates and Projections (2016-2027)
2.4.2 Europe Insulin API Estimates and Projections (2016-2027)
2.4.3 China Insulin API Estimates and Projections (2016-2027)
2.4.4 Japan Insulin API Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Insulin API Estimates and Projections (2016-2027)
2.4.6 India Insulin API Estimates and Projections (2016-2027)
3 Global Insulin API Competition Landscape by Players
3.1 Global Top Insulin API Players by Sales (2016-2021)
3.2 Global Top Insulin API Players by Revenue (2016-2021)
3.3 Global Insulin API Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Insulin API as of 2020)
3.4 Global Insulin API Average Price by Company (2016-2021)
3.5 Manufacturers Insulin API Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Insulin API Market Size by Type
4.1 Global Insulin API Historic Market Review by Type (2016-2021)
4.1.1 Global Insulin API Sales Market Share by Type (2016-2021)
4.1.2 Global Insulin API Revenue Market Share by Type (2016-2021)
4.1.3 Global Insulin API Price by Type (2016-2021)
4.2 Global Insulin API Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Insulin API Sales Forecast by Type (2022-2027)
4.2.2 Global Insulin API Revenue Forecast by Type (2022-2027)
4.2.3 Global Insulin API Price Forecast by Type (2022-2027)
5 Global Insulin API Market Size by Application
5.1 Global Insulin API Historic Market Review by Application (2016-2021)
5.1.1 Global Insulin API Sales Market Share by Application (2016-2021)
5.1.2 Global Insulin API Revenue Market Share by Application (2016-2021)
5.1.3 Global Insulin API Price by Application (2016-2021)
5.2 Global Insulin API Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Insulin API Sales Forecast by Application (2022-2027)
5.2.2 Global Insulin API Revenue Forecast by Application (2022-2027)
5.2.3 Global Insulin API Price Forecast by Application (2022-2027)

6 North America Insulin API Market Facts & Figures
6.1 North America Insulin API Sales by Company
6.1.1 North America Insulin API Sales by Company (2016-2021)
6.1.2 North America Insulin API Revenue by Company (2016-2021)
6.2 North America Insulin API Sales Breakdown by Type
6.2.1 North America Insulin API Sales Breakdown by Type (2016-2021)
6.2.2 North America Insulin API Sales Breakdown by Type (2022-2027)
6.3 North America Insulin API Sales Breakdown by Application
6.3.1 North America Insulin API Sales Breakdown by Application (2016-2021)
6.3.2 North America Insulin API Sales Breakdown by Application (2022-2027)

7 Europe Insulin API Market Facts & Figures
7.1 Europe Insulin API Sales by Company
7.1.1 Europe Insulin API Sales by Company (2016-2021)
7.1.2 Europe Insulin API Revenue by Company (2016-2021)
7.2 Europe Insulin API Sales Breakdown by Type
7.2.1 Europe Insulin API Sales Breakdown by Type (2016-2021)
7.2.2 Europe Insulin API Sales Breakdown by Type (2022-2027)
7.3 Europe Insulin API Sales Breakdown by Application
7.3.1 Europe 144 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 144 Sales Breakdown by Application (2022-2027)

8 China Insulin API Market Facts & Figures
8.1 China Insulin API Sales by Company
8.1.1 China Insulin API Sales by Company (2016-2021)
8.1.2 China Insulin API Revenue by Company (2016-2021)
8.2 China Insulin API Sales Breakdown by Type
8.2.1 China Insulin API Sales Breakdown by Type (2016-2021)
8.2.2 China Insulin API Sales Breakdown by Type (2022-2027)
8.3 China Insulin API Sales Breakdown by Application
8.3.1 China 311 Sales Breakdown by Application (2016-2021)
8.3.2 China 311 Sales Breakdown by Application (2022-2027)

9 Japan Insulin API Market Facts & Figures
9.1 Japan Insulin API Sales by Company
9.1.1 Japan Insulin API Sales by Company (2016-2021)
9.1.2 Japan Insulin API Revenue by Company (2016-2021)
9.2 Japan Insulin API Sales Breakdown by Type
9.2.1 Japan Insulin API Sales Breakdown by Type (2016-2021)
9.2.2 Japan Insulin API Sales Breakdown by Type (2022-2027)
9.3 Japan Insulin API Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Insulin API Market Facts & Figures
10.1 Southeast Asia Insulin API Sales by Company
10.1.1 Southeast Asia Insulin API Sales by Company (2016-2021)
10.1.2 Southeast Asia Insulin API Revenue by Company (2016-2021)
10.2 Southeast Asia Insulin API Sales Breakdown by Type
10.2.1 Southeast Asia Insulin API Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Insulin API Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Insulin API Sales Breakdown by Application
10.3.1 Southeast Asia Kg Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia Kg Sales Breakdown by Application (2022-2027)

11 India Insulin API Market Facts & Figures
11.1 India Insulin API Sales by Company
11.1.1 India Insulin API Sales by Company (2016-2021)
11.1.2 India Insulin API Revenue by Company (2016-2021)
11.2 India Insulin API Sales Breakdown by Type
11.2.1 India Insulin API Sales Breakdown by Type (2016-2021)
11.2.2 India Insulin API Sales Breakdown by Type (2022-2027)
11.3 India Insulin API Sales Breakdown by Application
11.3.1 India Insulin API Sales Breakdown by Application (2016-2021)
11.3.2 India Insulin API Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Insulin API Business
12.1 Novo Nordisk
12.1.1 Novo Nordisk Corporation Information
12.1.2 Novo Nordisk Business Overview
12.1.3 Novo Nordisk Insulin API Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Novo Nordisk Insulin API Products Offered
12.1.5 Novo Nordisk Recent Development
12.2 Sanofi-Aventis
12.2.1 Sanofi-Aventis Corporation Information
12.2.2 Sanofi-Aventis Business Overview
12.2.3 Sanofi-Aventis Insulin API Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Sanofi-Aventis Insulin API Products Offered
12.2.5 Sanofi-Aventis Recent Development
12.3 Eli Lilly
12.3.1 Eli Lilly Corporation Information
12.3.2 Eli Lilly Business Overview
12.3.3 Eli Lilly Insulin API Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Eli Lilly Insulin API Products Offered
12.3.5 Eli Lilly Recent Development
12.4 Tonghua Dongbao
12.4.1 Tonghua Dongbao Corporation Information
12.4.2 Tonghua Dongbao Business Overview
12.4.3 Tonghua Dongbao Insulin API Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Tonghua Dongbao Insulin API Products Offered
12.4.5 Tonghua Dongbao Recent Development
12.5 Ganlee
12.5.1 Ganlee Corporation Information
12.5.2 Ganlee Business Overview
12.5.3 Ganlee Insulin API Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Ganlee Insulin API Products Offered
12.5.5 Ganlee Recent Development
12.6 United Laboratory
12.6.1 United Laboratory Corporation Information
12.6.2 United Laboratory Business Overview
12.6.3 United Laboratory Insulin API Sales, Revenue and Gross Margin (2016-2021)
12.6.4 United Laboratory Insulin API Products Offered
12.6.5 United Laboratory Recent Development
12.7 Biocon
12.7.1 Biocon Corporation Information
12.7.2 Biocon Business Overview
12.7.3 Biocon Insulin API Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Biocon Insulin API Products Offered
12.7.5 Biocon Recent Development
12.8 Amphastar
12.8.1 Amphastar Corporation Information
12.8.2 Amphastar Business Overview
12.8.3 Amphastar Insulin API Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Amphastar Insulin API Products Offered
12.8.5 Amphastar Recent Development
12.9 Wockhardt
12.9.1 Wockhardt Corporation Information
12.9.2 Wockhardt Business Overview
12.9.3 Wockhardt Insulin API Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Wockhardt Insulin API Products Offered
12.9.5 Wockhardt Recent Development
12.10 Julphar Diabetes
12.10.1 Julphar Diabetes Corporation Information
12.10.2 Julphar Diabetes Business Overview
12.10.3 Julphar Diabetes Insulin API Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Julphar Diabetes Insulin API Products Offered
12.10.5 Julphar Diabetes Recent Development
12.11 Torrent Pharma
12.11.1 Torrent Pharma Corporation Information
12.11.2 Torrent Pharma Business Overview
12.11.3 Torrent Pharma Insulin API Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Torrent Pharma Insulin API Products Offered
12.11.5 Torrent Pharma Recent Development

13 Insulin API Manufacturing Cost Analysis
13.1 Insulin API Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Insulin API
13.4 Insulin API Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Insulin API Distributors List
14.3 Insulin API Customers

15 Market Dynamics
15.1 Insulin API Market Trends
15.2 Insulin API Drivers
15.3 Insulin API Market Challenges
15.4 Insulin API Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Insulin API Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Insulin API Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Insulin API Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Insulin API Sales (Kg) by Region (2016-2021)
Table 5. Global Insulin API Sales Market Share by Region (2016-2021)
Table 6. Global Insulin API Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Insulin API Revenue Share by Region (2016-2021)
Table 8. Global Insulin API Sales (Kg) Forecast by Region (2022-2027)
Table 9. Global Insulin API Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Insulin API Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Insulin API Revenue Share Forecast by Region (2022-2027)
Table 12. Global Insulin API Sales (Kg) of Key Companies (2016-2021)
Table 13. Global Insulin API Sales Share by Company (2016-2021)
Table 14. Global Insulin API Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Insulin API Revenue Share by Company (2016-2021)
Table 16. Global Insulin API by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Insulin API as of 2020)
Table 17. Global Insulin API Average Price (K USD/Kg) of Key Company (2016-2021)
Table 18. Manufacturers Insulin API Manufacturing Sites and Area Served
Table 19. Manufacturers Insulin API Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Insulin API Sales (Kg) by Type (2016-2021)
Table 22. Global Insulin API Sales Share by Type (2016-2021)
Table 23. Global Insulin API Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Insulin API Price (K USD/Kg) by Type (2016-2021)
Table 25. Global Insulin API Sales Share by Type (2022-2027)
Table 26. Global Insulin API Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Insulin API Revenue Share by Type (2022-2027)
Table 28. Global Insulin API Price (K USD/Kg) by Type (2022-2027)
Table 29. Global Insulin API Sales (Kg) by Application (2016-2021)
Table 30. Global Insulin API Sales Share by Application (2016-2021)
Table 31. Global Insulin API Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Insulin API Price (K USD/Kg) by Application (2016-2021)
Table 33. Global Insulin API Sales (Kg) by Application (2022-2027)
Table 34. Global Insulin API Sales Share by Application (2022-2027)
Table 35. Global Insulin API Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Insulin API Revenue Share by Application (2022-2027)
Table 37. Global Insulin API Price (K USD/Kg) by Application (2022-2027)
Table 38. North America Insulin API Sales (Kg) by Company (2016-2021)
Table 39. North America Insulin API Sales Market Share by Company (2016-2021)
Table 40. North America Insulin API Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Insulin API Revenue Market Share by Company (2016-2021)
Table 42. North America Insulin API Sales by Type (2016-2021) & (Kg)
Table 43. North America Insulin API Sales Market Share by Type (2016-2021)
Table 44. North America Insulin API Sales by Type (2022-2027) & (Kg)
Table 45. North America Insulin API Sales Market Share by Type (2022-2027)
Table 46. North America Insulin API Sales by Application (2016-2021) & (Kg)
Table 47. North America Insulin API Sales Market Share by Application (2016-2021)
Table 48. North America Insulin API Sales by Application (2022-2027) & (Kg)
Table 49. North America Insulin API Sales Market Share by Application (2022-2027)
Table 50. Europe Insulin API Sales (Kg) by Company (2016-2021)
Table 51. Europe Insulin API Sales Market Share by Company (2016-2021)
Table 52. Europe Insulin API Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Insulin API Revenue Market Share by Company (2016-2021)
Table 54. Europe Insulin API Sales by Type (2016-2021) & (Kg)
Table 55. Europe Insulin API Sales Market Share by Type (2016-2021)
Table 56. Europe Insulin API Sales by Type (2022-2027) & (Kg)
Table 57. Europe Insulin API Sales Market Share by Type (2022-2027)
Table 58. Europe Insulin API Sales by Application (2016-2021) & (Kg)
Table 59. Europe Insulin API Sales Market Share by Application (2016-2021)
Table 60. Europe Insulin API Sales by Application (2022-2027) & (Kg)
Table 61. Europe Insulin API Sales Market Share by Application (2022-2027)
Table 62. China Insulin API Sales (Kg) by Company (2016-2021)
Table 63. China Insulin API Sales Market Share by Company (2016-2021)
Table 64. China Insulin API Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Insulin API Revenue Market Share by Company (2016-2021)
Table 66. China Insulin API Sales by Type (2016-2021) & (Kg)
Table 67. China Insulin API Sales Market Share by Type (2016-2021)
Table 68. China Insulin API Sales by Type (2022-2027) & (Kg)
Table 69. China Insulin API Sales Market Share by Type (2022-2027)
Table 70. China Insulin API Sales by Application (2016-2021) & (Kg)
Table 71. China Insulin API Sales Market Share by Application (2016-2021)
Table 72. China Insulin API Sales by Application (2022-2027) & (Kg)
Table 73. China Insulin API Sales Market Share by Application (2022-2027)
Table 74. Japan Insulin API Sales (Kg) by Company (2016-2021)
Table 75. Japan Insulin API Sales Market Share by Company (2016-2021)
Table 76. Japan Insulin API Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Insulin API Revenue Market Share by Company (2016-2021)
Table 78. Japan Insulin API Sales by Type (2016-2021) & (Kg)
Table 79. Japan Insulin API Sales Market Share by Type (2016-2021)
Table 80. Japan Insulin API Sales by Type (2022-2027) & (Kg)
Table 81. Japan Insulin API Sales Market Share by Type (2022-2027)
Table 82. Japan Insulin API Sales by Application (2016-2021) & (Kg)
Table 83. Japan Insulin API Sales Market Share by Application (2016-2021)
Table 84. Japan Insulin API Sales by Application (2022-2027) & (Kg)
Table 85. Japan Insulin API Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Insulin API Sales (Kg) by Company (2016-2021)
Table 87. Southeast Asia Insulin API Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Insulin API Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Insulin API Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Insulin API Sales by Type (2016-2021) & (Kg)
Table 91. Southeast Asia Insulin API Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Insulin API Sales by Type (2022-2027) & (Kg)
Table 93. Southeast Asia Insulin API Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Insulin API Sales by Application (2016-2021) & (Kg)
Table 95. Southeast Asia Insulin API Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Insulin API Sales by Application (2022-2027) & (Kg)
Table 97. Southeast Asia Insulin API Sales Market Share by Application (2022-2027)
Table 98. India Insulin API Sales (Kg) by Company (2016-2021)
Table 99. India Insulin API Sales Market Share by Company (2016-2021)
Table 100. India Insulin API Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Insulin API Revenue Market Share by Company (2016-2021)
Table 102. India Insulin API Sales by Type (2016-2021) & (Kg)
Table 103. India Insulin API Sales Market Share by Type (2016-2021)
Table 104. India Insulin API Sales by Type (2022-2027) & (Kg)
Table 105. India Insulin API Sales Market Share by Type (2022-2027)
Table 106. India Insulin API Sales by Application (2016-2021) & (Kg)
Table 107. India Insulin API Sales Market Share by Application (2016-2021)
Table 108. India Insulin API Sales by Application (2022-2027) & (Kg)
Table 109. India Insulin API Sales Market Share by Application (2022-2027)
Table 110. Novo Nordisk Corporation Information
Table 111. Novo Nordisk Description and Business Overview
Table 112. Novo Nordisk Insulin API Sales (Kg), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2016-2021)
Table 113. Novo Nordisk Insulin API Product
Table 114. Novo Nordisk Recent Development
Table 115. Sanofi-Aventis Corporation Information
Table 116. Sanofi-Aventis Description and Business Overview
Table 117. Sanofi-Aventis Insulin API Sales (Kg), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2016-2021)
Table 118. Sanofi-Aventis Insulin API Product
Table 119. Sanofi-Aventis Recent Development
Table 120. Eli Lilly Corporation Information
Table 121. Eli Lilly Description and Business Overview
Table 122. Eli Lilly Insulin API Sales (Kg), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2016-2021)
Table 123. Eli Lilly Insulin API Product
Table 124. Eli Lilly Recent Development
Table 125. Tonghua Dongbao Corporation Information
Table 126. Tonghua Dongbao Description and Business Overview
Table 127. Tonghua Dongbao Insulin API Sales (Kg), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2016-2021)
Table 128. Tonghua Dongbao Insulin API Product
Table 129. Tonghua Dongbao Recent Development
Table 130. Ganlee Corporation Information
Table 131. Ganlee Description and Business Overview
Table 132. Ganlee Insulin API Sales (Kg), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2016-2021)
Table 133. Ganlee Insulin API Product
Table 134. Ganlee Recent Development
Table 135. United Laboratory Corporation Information
Table 136. United Laboratory Description and Business Overview
Table 137. United Laboratory Insulin API Sales (Kg), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2016-2021)
Table 138. United Laboratory Insulin API Product
Table 139. United Laboratory Recent Development
Table 140. Biocon Corporation Information
Table 141. Biocon Description and Business Overview
Table 142. Biocon Insulin API Sales (Kg), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2016-2021)
Table 143. Biocon Insulin API Product
Table 144. Biocon Recent Development
Table 145. Amphastar Corporation Information
Table 146. Amphastar Insulin API Sales (Kg), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2016-2021)
Table 147. Amphastar Description and Business Overview
Table 148. Amphastar Insulin API Product
Table 149. Amphastar Recent Development
Table 150. Wockhardt Corporation Information
Table 151. Wockhardt Insulin API Sales (Kg), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2016-2021)
Table 152. Wockhardt Description and Business Overview
Table 153. Wockhardt Insulin API Product
Table 154. Wockhardt Recent Development
Table 155. Julphar Diabetes Corporation Information
Table 156. Julphar Diabetes Description and Business Overview
Table 157. Julphar Diabetes Insulin API Sales (Kg), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2016-2021)
Table 158. Julphar Diabetes Insulin API Product
Table 159. Julphar Diabetes Recent Development
Table 160. Torrent Pharma Corporation Information
Table 161. Torrent Pharma Description and Business Overview
Table 162. Torrent Pharma Insulin API Sales (Kg), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2016-2021)
Table 163. Torrent Pharma Insulin API Product
Table 164. Torrent Pharma Recent Development
Table 165. Production Base and Market Concentration Rate of Raw Material
Table 166. Key Suppliers of Raw Materials
Table 167. Insulin API Distributors List
Table 168. Insulin API Customers List
Table 169. Insulin API Market Trends
Table 170. Insulin API Market Drivers
Table 171. Insulin API Market Challenges
Table 172. Insulin API Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Insulin API Product Picture
Figure 2. Global Insulin API Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Insulin API Sales Market Share by Application in 2021 & 2027
Figure 6. Fast-Acting Examples
Figure 7. Premix Examples
Figure 8. Long-Acting Examples
Figure 9. Global Insulin API Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Insulin API Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Insulin API Sales (Kg) Growth Rate (2016-2027)
Figure 12. Global Insulin API Price Trends Growth Rate (2016-2027) (K USD/Kg)
Figure 13. Global Insulin API Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Insulin API Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Insulin API Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Insulin API Sales (Kg) Growth Rate (2016-2027)
Figure 17. Europe Insulin API Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Insulin API Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Insulin API Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Insulin API Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Insulin API Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Insulin API Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Insulin API Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Insulin API Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Insulin API Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Insulin API Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Insulin API Players Market Share by Revenue in Insulin API: 2016 & 2020
Figure 28. Insulin API Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Insulin API Revenue Share by Type (2016-2021)
Figure 30. Global Insulin API Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Insulin API Revenue Share by Application (2016-2021)
Figure 32. Global Insulin API Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Insulin API Sales Market Share by Type in 2020
Figure 34. North America Insulin API Sales Market Share by Application in 2020
Figure 35. Europe Insulin API Sales Market Share by Type in 2020
Figure 36. Europe Insulin API Sales Market Share by Application in 2020
Figure 37. China Insulin API Sales Market Share by Type in 2020
Figure 38. China Insulin API Sales Market Share by Application in 2020
Figure 39. Japan Insulin API Sales Market Share by Type in 2020
Figure 40. Japan Insulin API Sales Market Share by Application in 2020
Figure 41. Southeast Asia Insulin API Sales Market Share by Type in 2020
Figure 42. Southeast Asia Insulin API Sales Market Share by Application in 2020
Figure 43. India Insulin API Sales Market Share by Type in 2020
Figure 44. India Insulin API Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Insulin API
Figure 47. Manufacturing Process Analysis of Insulin API
Figure 48. Insulin API Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed